Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial
Marieke M ter Wee, Veerle MH Coupé, Debby den Uyl, Birgit S Blomjous, Esmee Kooijmans, Pit JSM Kerstens, Mike T Nurmohamed, Dirkjan van Schaardenburg, Alexandre E Voskuyl, Maarten Boers, Willem F Lems
RMD Open Oct 2017, 3 (2) e000502; DOI: 10.1136/rmdopen-2017-000502